These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 122689

  • 1. The effects of miconazole on the ultrastructure of Candida albicans.
    De Nollin S, Borgers M, Van Belle H.
    Proc R Soc Med; 1977; 70 Suppl 4(Suppl 4):19-23. PubMed ID: 122689
    [No Abstract] [Full Text] [Related]

  • 2. [Study on classification and treatment of vulvovaginal candidiasis].
    Fan SR, Liu XP, Li JW, Xu AP, Liu M.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Aug; 40(8):532-5. PubMed ID: 16202291
    [Abstract] [Full Text] [Related]

  • 3. [The reaction of the physiological vaginal flora to topical antimycotics (author's transl)].
    Hantschke D, Zabel M.
    Mykosen; 1979 Aug; 22(8):267-73. PubMed ID: 398447
    [No Abstract] [Full Text] [Related]

  • 4. Development, characterization, and in vitro-in vivo evaluation of polymeric nanoparticles containing miconazole and farnesol for treatment of vulvovaginal candidiasis.
    Fernandes Costa A, Evangelista Araujo D, Santos Cabral M, Teles Brito I, Borges de Menezes Leite L, Pereira M, Correa Amaral A.
    Med Mycol; 2019 Jan 01; 57(1):52-62. PubMed ID: 29361177
    [Abstract] [Full Text] [Related]

  • 5. Butoconazole vaginal cream in the treatment of vulvovaginal candidiasis. Comparison with miconazole nitrate and placebo.
    Brown D, Henzl MR, LePage ME, Tsao LL, Izu AE, Walker KA, Adamson GD, Droegmuller W.
    J Reprod Med; 1986 Nov 01; 31(11):1045-8. PubMed ID: 3543342
    [Abstract] [Full Text] [Related]

  • 6. Terconazole and miconazole cream for treating vulvovaginal candidiasis. A comparison.
    Corson SL, Kapikian RR, Nehring R.
    J Reprod Med; 1991 Aug 01; 36(8):561-7. PubMed ID: 1941796
    [Abstract] [Full Text] [Related]

  • 7. Treatment of candidal vaginitis with miconazole, a new broad-spectrum antimycotic. Changes in microbiology, vaginal pH and cytology.
    Peeters F, Snauwaert R, Segers J, Van Cutsem J, Amery W.
    Arzneimittelforschung; 1973 Aug 01; 23(8):1107-11. PubMed ID: 4588098
    [No Abstract] [Full Text] [Related]

  • 8. Miconazole loaded chitosan-based nanoparticles for local treatment of vulvovaginal candidiasis fungal infections.
    Amaral AC, Saavedra PHV, Oliveira Souza AC, de Melo MT, Tedesco AC, Morais PC, Soares Felipe MS, Bocca AL.
    Colloids Surf B Biointerfaces; 2019 Feb 01; 174():409-415. PubMed ID: 30481701
    [Abstract] [Full Text] [Related]

  • 9. Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis.
    Kenechukwu FC, Attama AA, Ibezim EC, Nnamani PO, Umeyor CE, Uronnachi EM, Gugu TH, Momoh MA, Ofokansi KC, Akpa PA.
    Eur J Pharm Sci; 2018 Jan 01; 111():358-375. PubMed ID: 28986195
    [Abstract] [Full Text] [Related]

  • 10. Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole.
    Rautemaa R, Richardson M, Pfaller M, Perheentupa J, Saxen H.
    Scand J Infect Dis; 2008 Jan 01; 40(11-12):904-7. PubMed ID: 18651265
    [Abstract] [Full Text] [Related]

  • 11. Treatment of vaginal candidiasis in pregnant women.
    Weisberg M.
    Clin Ther; 1986 Jan 01; 8(5):563-7. PubMed ID: 3768930
    [Abstract] [Full Text] [Related]

  • 12. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
    Kurnatowski P, Makieło L, Horwatt-Bozyczko E.
    Wiad Parazytol; 2001 Jan 01; 47(4):867-73. PubMed ID: 16886440
    [Abstract] [Full Text] [Related]

  • 13. [Vaginal candidiasis--treatment protocols using miconazole and fluconazole].
    Mazneĭkova V.
    Akush Ginekol (Sofiia); 2003 Jan 01; 42 Suppl 2():30-4. PubMed ID: 14619753
    [Abstract] [Full Text] [Related]

  • 14. The effects of miconazole on the ultrastructure of Candida albicans.
    de Nollin S, Borgers M.
    Proc R Soc Med; 1977 Jan 01; 70 Suppl 1(Suppl 1):9-12. PubMed ID: 233843
    [Abstract] [Full Text] [Related]

  • 15. Candida albicans isolates from APECED patients show decreased susceptibility to miconazole.
    Siikala E, Richardson M, Pfaller MA, Diekema DJ, Messer SA, Perheentupa J, Saxén H, Rautemaa R.
    Int J Antimicrob Agents; 2009 Dec 01; 34(6):607-9. PubMed ID: 19748230
    [No Abstract] [Full Text] [Related]

  • 16. Problems in the laboratory assessment of antifungal activity.
    Odds FC.
    Postgrad Med J; 1979 Sep 01; 55(647):677-80. PubMed ID: 392483
    [Abstract] [Full Text] [Related]

  • 17. Azole resistance in Candida albicans.
    Smith KJ, Warnock DW, Kennedy CT, Johnson EM, Hopwood V, Van Cutsem J, Vanden Bossche H.
    J Med Vet Mycol; 1986 Apr 01; 24(2):133-44. PubMed ID: 3014106
    [Abstract] [Full Text] [Related]

  • 18. Action of miconazole at high concentrations against Candida albicans.
    D'Auria FD, Villa A, Simonetti N.
    J Chemother; 1989 Jul 01; 1(4 Suppl):240-2. PubMed ID: 16312385
    [No Abstract] [Full Text] [Related]

  • 19. The antifungal imidazoles: clotrimazole and miconazole.
    Milne LJ.
    Scott Med J; 1978 Apr 01; 23(2):149-52. PubMed ID: 644298
    [No Abstract] [Full Text] [Related]

  • 20. Miconazole nitrate vaginal suppository 1,200 mg versus oral fluconazole 150 mg in treating severe vulvovaginal candidiasis.
    Fan S, Liu X, Liang Y.
    Gynecol Obstet Invest; 2015 Apr 01; 80(2):113-8. PubMed ID: 25720546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.